Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice

Gallic Acid Improves Diabetic Steatosis by Downregulating MicroRNA-34a-5p through Targeting NFE2L2 Expression in High-Fat Diet-Fed db/db Mice

Type 2 diabetes mellitus (T2DM) has become epidemic worldwide and is strongly associated with nonalcoholic fatty liver disease (NAFLD). The molecular mechanisms of microRNAs in NAFLD and T2DM development and the corresponding therapies remain unclear. We performed microRNA microarray validation to d...

Full description

Bibliographic Details
Main Authors:	Ang-Tse Lee, Mon-Yuan Yang, Yi-Ju Lee, Tzu-Wei Yang, Chi-Chih Wang, Chau-Jong Wang
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Antioxidants
Subjects:	microRNA lipogenesis diabetic steatosis gallic acid NFE2L2
Online Access:	https://www.mdpi.com/2076-3921/11/1/92

Similar Items

Gallic acid ameliorates diabetic steatohepatitis in db/db mice fed with a high-fat diet
by: Chi-Chih Wang, et al.
Published: (2025-03-01)

NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
by: Kamila Łuczyńska, et al.
Published: (2024-02-01)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
by: Guiyi Ji, et al.
Published: (2021-05-01)

Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
by: Kewei Wang, et al.
Published: (2023-10-01)

Cardamonin Reduces Acetaminophen-Induced Acute Liver Injury in Mice via Activating Autophagy and NFE2L2 Signaling
by: Qiushi Xu, et al.
Published: (2020-11-01)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
by: Panshuang Qiao, et al.
Published: (2022-08-01)

Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma
by: Yuancai Xiang, et al.
Published: (2024-03-01)

The roles of NFE2L1 in adipocytes: Structural and mechanistic insight from cell and mouse models
by: Suping Ren, et al.
Published: (2021-08-01)

Unravelling the role of NFE2L1 in stress responses and related diseases
by: Xingzhu Liu, et al.
Published: (2023-09-01)

Anti-hyperglycemic effects of Cissus quadrangularis extract via regulation of gluconeogenesis in type 2 diabetic db/db mice
by: Jeong-Won Kim, et al.
Published: (2024-07-01)

NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism
by: Jiao Liu, et al.
Published: (2024-11-01)

Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases
by: Aswathy Chandran, et al.
Published: (2023-08-01)

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
by: Mustafa Elshani, et al.
Published: (2023-08-01)

Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
by: Shuo Yu, et al.
Published: (2024-04-01)

Maternal Calorie Restriction Induces a Transcriptional Cytoprotective Response in Embryonic Liver Partially Dependent on Nrf2
by: George I. Habeos, et al.
Published: (2022-11-01)

Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
by: Mengxiao Liu, et al.
Published: (2022-06-01)

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
by: Margarita Vida, et al.
Published: (2015-07-01)

Multi-Omics Analysis of <i>NFE2L2</i>-Altered TCGA-Cervical Squamous Cell Carcinoma Patients
by: Sri Vidya Ramisetti, et al.
Published: (2023-03-01)

Understanding the Transcription Factor NFE2L1/NRF1 from the Perspective of Hallmarks of Cancer
by: Haomeng Zhang, et al.
Published: (2024-06-01)

New insight into the CNC-bZIP member, NFE2L3, in human diseases
by: Guanghui Xiong, et al.
Published: (2024-07-01)

Impact of Genomic Variation of NFE2L2 (rs6706649) on Serum Glyoxalase-1 Levels in A Sample of Iraqi Type 2 Diabetic Patients with Retinopathy
by: Sarah Hashim Mhaibes, et al.
Published: (2025-02-01)

NFE2L3 as a Novel Biomarker Associated With IL-2/STAT5/NLRP3 Signaling Pathway in Malignant Pleural Mesothelioma and Other Cancers
by: Zhen Wang, et al.
Published: (2022-05-01)

The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway
by: Yuhong Huang, et al.
Published: (2024-01-01)

CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]
by: Robin D. Clugston, et al.
Published: (2014-02-01)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
by: Zhai M, et al.
Published: (2021-03-01)

Prevalence and Associations of Co-occurrence of <i>NFE2L2</i> Mutations and Chromosome 3q26 Amplification in Lung Cancer
by: Jinfeng Liu, et al.
Published: (2024-06-01)

Alterations in the Transcriptional Profile of the Liver Tissue and the Therapeutic Effects of Propolis Extracts in Alcohol-induced Steatosis in Rats
by: MANHONG YE, et al.

Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
by: Li Luo, et al.
Published: (2019-01-01)

Single-nucleus RNA-sequencing reveals NRF1/NFE2L1 as a key factor determining the thermogenesis and cellular heterogeneity and dynamics of brown adipose tissues in mice
by: Wei Shen, et al.
Published: (2023-11-01)

Effects of Heat-Induced Oxidative Stress and Astaxanthin on the <i>NF-kB</i>, <i>NFE2L2</i> and <i>PPARα</i> Transcription Factors and Cytoprotective Capacity in the Thymus of Broilers
by: Donna Lee Kuehu, et al.
Published: (2024-08-01)

The alleviation of lipid deposition in steatosis hepatocytes by capsaicin-loaded α-lactalbumin nanomicelles via promoted endocytosis and synergetic multiple signaling pathways
by: Congcong Zuo, et al.
Published: (2021-04-01)

Effect of Roselle Flower Extract (<i>Hibiscus sabdariffa</i> Linn.) on Reducing Steatosis and Steatohepatitis in Vitamin B12 Deficiency Rat Model
by: Irena Ujianti, et al.
Published: (2023-05-01)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
by: Yue-chu Dai, et al.
Published: (2021-12-01)

Glycycoumarin prevents hepatic steatosis through activation of adenosine 5,-monophosphate (AMP)-activated protein kinase signaling pathway and up-regulation of BTG1/Tob-1
by: Enxiang Zhang, et al.
Published: (2017-07-01)

Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
by: Xing Jin, et al.
Published: (2021-12-01)

Sema7A protects against high-fat diet-induced obesity and hepatic steatosis by regulating adipo/lipogenesis
by: Qiongyu Lu, et al.
Published: (2023-04-01)

Diphlorethohydroxycarmalol Attenuates Palmitate-Induced Hepatic Lipogenesis and Inflammation
by: Seon-Heui Cha, et al.
Published: (2020-09-01)

Mulberry leaf extract displays antidiabetic activity in db/db mice via Akt and AMP-activated protein kinase phosphorylation
by: Ui-Jin Bae, et al.
Published: (2018-08-01)

NFE2/miR-423-5p/TFF1 axis regulates high glucose-induced apoptosis in retinal pigment epithelial cells
by: Qing Xiao, et al.
Published: (2019-08-01)

Phyllodulcin, a natural functional sweetener, improves diabetic metabolic changes by regulating hepatic lipogenesis, inflammation, oxidative stress, fibrosis, and gluconeogenesis in db/db mice
by: Eunju Kim, et al.
Published: (2018-03-01)